Table 3. Main baseline characteristics of the women with non remittent asthma and with remittent asthma at follow-up and adjusted Odds Ratios^* (CI95%) for the effects of these variables reported at baseline on asthma remission at follow-up.

	Non remittent asthma	Remittent asthma	Unadjusted p-value	Adjusted OR* (CI95%)
	n = 81	n = 33
Age at baseline (years), mean(sd)	34.6 (6.9)	35.9 (8.5)	0.431	1.00 (0.94;1.06)
Smoking habits (%)£			0.452
Non smoker	54.3	48.5		1.0
Ex-smoker	23.5	18.2		0.39 (0.03;5.66)
Current smoker	22.2	33.3		3.82 (0.56;26.27)
Age at onset of asthma (years), median	14	19.5	0.027	1.07 (1.00;1.14)
Age at onset of asthma (years), (IQR) §	(5–25)	(12–31.5)
ICS use in the last 3 mo. at baseline (%)	39.2	21.98	0.081	0.53 (0.27;1.06)
Asthma control at baseline (%) ‡			0.425
Total control	31.6	37.5		1.00
Partial control	30.4	37.5		0.71 (0.20;2.47)
No control	38.0	25.0		0.40 (0.17;0.94)
Allergic rhinitis (%)	72.8	72.7	0.990	1.49 (0.78;2.85)

^*Also adjusted for the type of interview (telephone vs face to face).

£ Overall adjusted p-value for smoking <0.0001.

^§IQR, Interquartile Range: (1^st quartile–3^rd quartile).

^‡Overall adjusted p-value for asthma control at baseline  = 0.0791.

Significant unadjusted p-value and adjusted OR (p<0.05) are reported in bold.